Biologicals/biosimilar approved in EU and marketed in SI

Biosimilars approved in the EU published at EMA website – LINK

By clicking on an individual drug, the following information is displayed: overview about the drug in English and Slovenian, authorization details in English, Summary of the main characteristics of the drug – SmPC – in Slovenian and English, Assessment history (EPAR) in English.

Information on the current status of the drug’s presence on the Slovenian market is available on the website of the central drug database: Central drug database 2 – Search (cbz.si)

Scroll to Top